Ledger.Open graph →
SEC Form D · filed March 18, 2021

Cytonus Therapeutics, Inc

Offering
$5.0M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
COLUMBUS, OH
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Christopher Thorne · Columbus, OHDirectorManisha Narasimhan · Columbus, OHDirectorRichard Klemke · Columbus, OHDirectorRemo Moomiaie · Columbus, OHExec · DirectorKen Johnson · Mt. Laurel, NJDirectorSarah Marriott · San Francisco, CAExec · DirectorParent of the General Partner Richard Impax Asset Management Group PLC · London, United KingdomDirectorIan R. Simm · London, United KingdomDirectorDavid E. Finley · Boston, MAExec · DirectorKirsten P. Morin · Boston, MADirectorPeter W. Mooradian · Boston, MADirectorBenjamin T. Rubin · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗